Active Surveillance of Renal Cortical Neoplasms: A contemporary review

Postgraduate Medicine

Volumn 123, Issue 1, 2011, Pages 105-113

  Graversen, Joseph A ^a   Mues, Adam C ^a   de Lorca, Alberto Pérez Lanzac ^a   Landman, Jaime ^b  

^a New York Presbyterian Morgan Stanley Children's Hospital   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Active surveillance; Renal biopsy; Renal mass; Small renal mass

Indexed keywords

AGE; COMORBIDITY; DISEASE COURSE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INFORMATION RETRIEVAL; KIDNEY CORTEX TUMOR; KIDNEY TUMOR; LIFE EXPECTANCY; MEDICAL DECISION MAKING; MEDLINE; METASTASIS; PATIENT DECISION MAKING; PATIENT SELECTION; REVIEW; SURGICAL RISK; TREATMENT INDICATION; TUMOR BIOPSY; TUMOR GROWTH; TUMOR VOLUME; WATCHFUL WAITING; METHODOLOGY; MORTALITY; PATHOLOGY; PROGNOSIS;

DISEASE PROGRESSION; HUMANS; KIDNEY NEOPLASMS; NEOPLASM METASTASIS; PROGNOSIS; WATCHFUL WAITING;

EID: 79952789126     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2011.01.2251     Document Type: Review

References (54)

1. Novick AC, Campbell SC, Belldegrun A, et al. Guideline for management of the clinical stage 1 renal mass. American Urological Association. 2009. http://www.auanet.org/content/guidelines-and-quality-care/clinical-guidelines.cfm. Accessed September 7, 2010.
2. Clayman RV, Kavoussi LR, Soper NJ, et al. Laparoscopic nephrectomy: initial case report. J Urol. 1991; 146(2): 278-282.
3. Huang HC, Levey AS, Serio AM, et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol. 2006; 7(9): 735-740.
4. McKiernan J. Simmons R, Katz J, Russo P. Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology. 2006; 59(6): 819-820.
5. Bijol V, Mendez GP, Hurwitz S, et al. Evaluation of the nonneoplastic pathology in tumor nephrectomy specimens: predicting the risk of progressive renal failure. Am J Surg Pathol. 2006; 30(5): 575-584.
6. Thompson RH, Boorjian SA, Lohse CM, et al. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J Urol. 2008; 179(2): 468-473.
7. Delworth MG, Pisters LL, Fornage BD, von Eschenbach AC. Cryotherapy for renal cell carcinoma and angiomyolipoma. J Urol. 1996; 155(1): 252-255.
8. Allen BC, Remer EM. Percutaneous cryoablation of renal tumors: patient selection, technique, and postprocedural imaging. Radiographics. 2010; 30(4): 887-902.
9. Aron M, Kamoi K, Remer E, et al. Laparoscopic renal cryoablation: 8-year, single surgeon outcomes. J Urol. 2010; 183(3): 889-895.
10. Kimura M, Baba S, Polascik TJ. Minimally invasive surgery using ablative modalities for the localized renal mass. Int J Urol. 2010; 17(3): 215-217.
11. Leveridge MJ, Mattar K, Kachura J, Jewett MA. Assessing outcomes in probe ablative therapies for small renal masses. J Endourol. 2010; 24(5): 759-764.
12. Levinson AW, Su LM, Agarwal D, et al. Long-term oncological and overall outcomes of percutaneous radio frequency ablation in high risk surgical patients with a solitary small renal mass. J Urol. 2008; 180(2): 499-504.
13. Gervais DA, McGovern FJ, Arellano RS, et al. Radiofrequency ablation of renal cell carcinoma: part I, indications, results and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol. 2005; 185(1): 64-71.
14. Zagoria RJ, Traver MA, Werle DM, et al. Oncologic efficacy of CTguided percutaneous radiofrequency ablation of renal cell carcinomas. AJR Am J Roentgenol. 2007; 189(2): 429-436.
15. Matin SF, Ahrar K, Cadeddu JA, et al. Residual and recurrent disease following renal energy ablative therapy: a multi-institutional study. J Urol. 2006; 176(5): 1973-1977.
16. Chawla AN, Crispen PL, Hanlon AL, Greenberg RE, Chen DY, Uzzo RG. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol. 2006; 175(2): 425-431.
17. Rosales JC, Haramis G, Moreno J, et al. Active surveillance of renal cortical neoplasms. J Urol. 2010; 183(5): 1698-1702.
18. Remzi M, Özsoy M, Klingler HC, et al. Are small renal tumors harmless? Analysis of histopathological features according to tumors 4 cm or less in diameter. J Urol. 2006; 176(3): 896-899.
19. Lane BR, Babineau D, Kattan MW, et al. A preoperative nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy. J Urol. 2007; 178(2): 429-434.
20. Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol. 2003; 170(6 pt 1): 2217-2220.
21. Bosniak MA, Birnbaum BA, Krinsky GA, et al. Small renal parynchemal neoplasms: further observations on growth. Radiology. 1995; 197(3): 589-597.
22. Bosniak MA. Observation of small incidentally detected renal masses. Semin Urol Oncol. 1995; 13(4): 267-272.
23. Crispen PL, Viterbo R, Boorjian SA, Greenberg RE, Chen DY, Uzzo RG. Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillance. Cancer. 2009; 115(13): 2844-2852.
24. Siu W, Hafez KS, Johnston WK 3rd, Wolf JS Jr. Growth rates of renal cell carcinoma and oncocytoma under surveillance are similar. Urol Oncol. 2007; 25(2): 115-119.
25. Abouassaly R, Lane BR, Novick AC. Active surveillance of renal masses in elderly patients. J Urol. 2008; 180: 505-509.
26. Fujimoto N, Sugita A, Terasawa Y, et al. Observations on the growth rate of renal cell carcinoma. Int J Urol. 1995; 2(2): 71-76.
27. Kato M, Suzuki T, Suzuki Y, et al. Natural history of small renal cell carcinoma: evaluation of growth rate, histological grade, cell proliferation and apoptosis. J Urol. 2004; 172(3): 863-866.
28. Rendon RA, Stanietzky N, Panzarella T, et al. The natural history of small renal masses. J Urol. 2000; 164(4): 1143-1147.
29. Oda T, Miyao N, Takashi A, et al. Growth rates of primary and metastatic lesions of renal cell carcinoma. Int J Urol. 2001; 8(9): 473-477.
30. Kassouf W, Aprikian AG, Laplante M, Tanguay S. Natural history of renal masses followed expectantly. J Urol. 2004; 171(1): 111-113.
31. Volpe A, Panzarella T, Rendon R, Halder MA, Kondylis FI, Jewett MA. The natural history of incidentally detected small renal masses. Cancer. 2004; 100(4): 738-745.
32. Wehle, MJ, Thiel DD, Petrou SP, Young PR, Frank I, Karsteadt N. Conservative management of incidental contrast-enhancing renal masses as safe alternative to invasive therapy. Urology. 2004; 64(1): 49-52.
33. Sowery RD, Siemens DR. Growth characteristics of renal cortical tumors in patients managed by watchful waiting. Can J Urol. 2004; 11(5): 2407-2410.
34. Lamb GW, Bromwich EJ, Vasey P, et al. Management of renal masses in patients medically unsuitable for nephrectomy-natural history, complications, and outcome. Urology. 2004; 64(5): 909-913.
35. Kouba E, Smith A, McRacken D, Wallen EM, Pruthi RS. Watchful waiting for solid renal masses: insight into the natural history and results of delayed intervention. J Urol. 2007; 177(2): 466-470.
36. Abou Youssif T, Kassouf W, Steinberg J, Aprikian AG, Laplante MP, Tanguay S. Active surveillance for selected patients with renal masses: updated results with long-term follow-up. Cancer. 2007; 110(5): 1010-1014.
37. Van Poppel H, Joniau. Is surveillance an option for the treatment of small renal masses? Eur Urol. 2007; 52(5): 1323-1330.
38. Ozono S, Miyao N, Igarashi T, et al. Tumor doubling time of renal cell carcinoma measured by CT: collaboration of Japanese Society of Renal Cancer. Jpn J Clin Oncol. 2004; 34(2): 82-85.
39. Schlomer B, Figenshau RS, Yan Y, Venkatesh R, Bhayani SB. Pathological features of renal neoplasms classified by size and symptomatology. J Urol. 2006; 176(4 pt 1): 1317-1320.
40. Kunkle DA, Crispen PL, Chen DY, Greenberg RE, Uzzo RG. Enhancing renal mases with zero net growth during active surveillance. J Urol. 2007; 177(3): 849-854.
41. Kunkle DA, Crispen PL, Li T, Uzzo RG. Tumor size predicts synchronous metastatic renal cell carcinoma: implications for surveillance of small renal masses. J Urol. 2007; 177(5): 1692-1697.
42. Minardi D, Lucarini G, Mazzucchelli R, et al. Prognostic role of Fuhrman grade and vascular endothelial growth factor in pT1a clear cell carcinoma in partial nephrectomy specimens. J Urol. 2005; 174 (4 pt 1): 1208-1212.
43. Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol. 2002; 168(6): 2395-2400.
44. Zisman A, Pantuck AJ, Dorey F, et al. Improved prognostication of renal cell carcinoma using an integrated scoring system. J Clin Oncol. 2001; 19(6): 1649-1657.
45. Kattan MW, Reuter V, Motzer RJ, Katz J, Russo P. A postoperative prognostic nomogram for renal cell carcinoma. J Urol. 2001; 166(1): 63-67.
46. Haramis G, Mues AC, Rosales JC, et al. The natural history of renal cortical neoplasms on active surveillance with longer than 5 year follow-up [published online ahead of print March 27, 2010]. J Urol. 2010.
47. Mues AC, Haramis G, Badani K, et al. Active surveillance for larger (cT1bN0M0 and cT2N0M0) renal cortical neoplasms. Urology. 2010; 76(3): 620-623.
48. Campbell SC, Novick AC, Herts B, et al. Prospective evaluation of fine needle aspiration of small, solid renal masses: accuracy and morbidity. Urology. 1997; 50(1): 25-29.
49. Dechet CB, Zincke H, Sebo TJ, et al. Prospective analysis of computerized tomography and needle biopsy with permanent sectioning to determine the nature of solid renal masses in adults. J Urol. 2003; 169(1): 71-74.
50. Neuzillet Y, Lechevallier E, Andre M, et al. Accuracy and clinical role of fine needle percutaneous biopsy with computerized tomography guidance of small (less than 4.0 cm) renal masses. J Urol. 2004; 171(5): 1802-1805.
51. Maturen KE, Nghiem HV, Caoili EM, Higgins EG, Wolf JS Jr, Wood DP Jr. Renal mass core biopsy: accuracy and impact on clinical management. AJR Am J Roentgenol. 2007; 188(2): 563-570.
52. Gill IS, Aron M, Gervais DA, Jewett MA. Small renal mass. N Engl J Med. 2010; 362(7): 624-634.
53. Rybicki FJ, Shu KM, Cibas ES, et al. Percutaneous biopsy of renal masses: sensitivity and negative predictive value stratified by clinical setting and size of masses. AJR Am J Roentgenol. 2003; 180(5): 1281-1287.
54. Shannon BA, Cohen RJ, de Bruto H, et al. The value of preoperative needle core biopsy for diagnosing benign lesions among small incidentally detected renal masses. J Urol. 2008; 180(4): 1257-1261.